Charles River Laboratories International Inc - Company Profile
Powered by 
All the data and insights you need on Charles River Laboratories International Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Charles River Laboratories International Inc Strategy Report
- Understand Charles River Laboratories International Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Charles River Laboratories International Inc (Charles River), is a contract research organization (CRO) that provides essential products and services to accelerate research, drug discovery and development. It offers various basic research, drug discovery and safety assessment services. The company also offers clinical, manufacturing and operations and staffing support. It provides solutions focused on therapy areas related to cardiovascular, central nervous system, metabolic, inflammation, oncology, ophthalmology, respiratory, and musculoskeletal disorders. Charles River provides products and services to pharmaceutical and biotechnology companies, government agencies, besides leading hospitals and academic institutions. Charles River is headquartered in Wilmington, Massachusetts, the US.
Headquarters
United States of America
Address
251 Ballardvale St, Wilmington, Massachusetts, 01887
Website
www.criver.com
Telephone
1 781 2226000
No of Employees
20,000
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
CRL (NYSE)
Revenue (2022)
$4.1B
3.9%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
-2.4%
(2022 vs 2021)
Market Cap*
$12.4B
Net Profit Margin (2022)
XYZ
-6.1%
(2022 vs 2021)
* As of and is in US$
Charles River Laboratories International Inc premium industry data and analytics
Products and Services
| Services |
|---|
| Antibody Production Services |
| Biopharmaceutical Services |
| Avian Vaccine Services |
| XYZ |
| XYZ |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | Contracts/Agreements | In April, the company signed a Good Manufacturing Practice plasmid DNA contract development and manufacturing organization agreement with Ship of Theseus to support Charles River’s premier expertise in manufacturing GMP plasmid DNA. |
| 2024 | New Products/Services | In April, the company launched the same-day delivery of fresh leukopaks to Cambridge, Greater Boston, and the San Diego biohub. |
| 2024 | Contracts/Agreements | In April, the company signed an agreement with Deciphex to introduce Patholytix Foresight. |
Competitor Comparison
| Key Parameters | Charles River Laboratories International Inc | Almac Group Ltd | BioReliance Corp | Corgenix Medical Corp | IMR Partner International Medical Research GmbH |
|---|---|---|---|---|---|
| Headquarters | United States of America | United Kingdom | United States of America | United States of America | Germany |
| City | Wilmington | Craigavon | Rockville | Broomfield | Grafelfing |
| State/Province | Massachusetts | Northern Ireland | Maryland | Colorado | Bayern |
| No. of Employees | 20,000 | 6,600 | - | - | - |
| Entity Type | Public | Private | Private | Private | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| James C. Foster | President; Chairman; Chief Executive Officer | Executive Board | 2000 | 72 |
| Flavia H. Pease | Executive Vice President; Chief Financial Officer | Senior Management | 2022 | - |
| Birgit Girshick | Corporate Executive Vice President; Chief Operating Officer | Senior Management | 2021 | 52 |
| Michael G. Knell | Chief Accounting Officer; Senior Vice President | Senior Management | 2017 | - |
| John C. Ho, M.D. | Senior Vice President - Corporate Strategy; Chief Strategy Officer | Senior Management | 2012 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward